Shiratori Pharmaceutical

Shiratori Pharmaceutical is an API manufacturer in Japan focusing on APIs for niche markets such as rare diseases, rare oncology and neurology, including high-potency APIs, with manufacturing patents applied for Tafamidis and Eltrombopag in Japan. Its API pipeline includes Trametinib, Cabazitaxel Acetonate, Opicapone, Ixazomib Citrate, Brexpiprazole, Valbenazine Tosylate, Esaxerenone, Pemafibrate, Omidenepag, Daprodustat, Macitentan, Riociguat, Selexipag and Tafamidis.